Form EFFECT Quoin Pharmaceuticals,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 4, 2025 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Quoin Pharmaceuticals publishes peer-reviewed paper on QRX003 for rare skin disease
- XRP Price Prediction: Arf Brings Its $10B Annual Settlement Business to XRPL as Remittix Plans 41 More Fiat Currencies
- Best Crypto Presale to Buy in 2026? Can Remittix’s 300M RTX Burn Plan Outshine Solana and Zcash?
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share